OBGYN.net Broadcasting presents Part V of a series of presentations on Weight Loss Surgery. This project is unique in that we follow the patient from pre-op to one year post-op.
<a href="http://av.obgyn.net/ramgen/roberta/partV/part5.rm">Click here to experience the presentation </a></A>
OBGYN.net Broadcasting presents Part V of a series of presentations on Weight Loss Surgery. This project is unique in that we follow the patient from pre-op to one year post-op. The patient is Roberta Speyer, Publisher of OBGYN.net. Funding for this project was provided by InnerDyne® Inc., BioEnterics Corp., and Richard Wolf Instruments. In Part V, the viewer sees the ending of surgery and interviews with several members of the surgery team.
At this time, three years post-op, Roberta is satisfied with the outcome of her surgery and hopes you have found her story helpful in your search for answers. Please direct any questions about LAP BAND surgery to your personal physician, or email the product makers directly at: http://www.inamed.com/contact/bio_patient.cgi. Due to time restraints Roberta Speyer and the OBGYN.net team cannot respond to personal emails. See Professor Rudolf Weiner's website about Weight Loss Surgery to see if this option is right for you. Visit www.profweiner.com.
click on the play button above to start the video
You will need RealPlayer to download the streaming video of this presentation. If you need a FREE copy of RealPlayer you can download it here.
Text version of this presentation
FDA grants IND clearance to DARE-VVA1 for dyspareunia
December 7th 2023Daré Bioscience's tamoxifen-based therapy, DARE-VVA1, secures FDA clearance for an investigational new drug application, offering hope for women with contraindications to estrogen therapies suffering from the underdiagnosed condition of vulvar and vaginal atrophy.
Read More
Treating heavy menstrual bleeding: Levonorgestrel system vs combined oral contraceptives
November 8th 2023In a recent study, patients who were treated for heavy menstrual bleeding with the levonorgestrel intrauterine system had similar changes in bleeding-related quality of life as those using combined oral contraceptives for treatment.
Read More